 Connection
Larry Moreland to Immunotherapy
This is a "connection" page, showing publications Larry Moreland has written about Immunotherapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.229 |
|
|
|
-
Moreland LW. Initial experience combining methotrexate with biologic agents for treating rheumatoid arthritis. J Rheumatol Suppl. 1996 Mar; 44:78-83.
Score: 0.099
-
Moreland LW, Bucy RP, Tilden A, Pratt PW, LoBuglio AF, Khazaeli M, Everson MP, Daddona P, Ghrayeb J, Kilgarriff C, et al. Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis. Arthritis Rheum. 1993 Mar; 36(3):307-18.
Score: 0.081
-
Drevlow BE, Lovis R, Haag MA, Sinacore JM, Jacobs C, Blosche C, Landay A, Moreland LW, Pope RM. Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis. Arthritis Rheum. 1996 Feb; 39(2):257-65.
Score: 0.025
-
Moreland LW, Heck LW, Koopman WJ, Saway PA, Adamson TC, Fronek Z, O'Connor RD, Morgan EE, Diveley JP, Chieffo NM, et al. V beta 17 T-cell receptor peptide vaccine. Results of a phase I dose-finding study in patients with rheumatoid arthritis. Ann N Y Acad Sci. 1995 Jul 07; 756:211-4.
Score: 0.024
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|